Nanoscope Therapeutics

Nanoscope Therapeutics Names New Vice President of Quality

by | Jan 11, 2023

Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.

Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products.

“Massoud’s experience leading quality and compliance in CGMP manufacturing for gene therapies will be valuable as we progress in our chemistry, manufacturing, and controls (CMC) capabilities....

MORE
Nanoscope Therapeutics Adds 2 Execs to Chemistry, Manufacturing, Controls Team
by | Nov 11, 2022
Dallas-based Nanoscope Therapeutics is developing therapies that could restore sight in patients. The company also recently announced a new gene therapy manufacturing partnership.
MORE
Nanoscope Therapeutics Accelerates Sight-Restoring Drug Development with New Gene Therapy Manufacturing Partnership
by | Oct 18, 2022
Dallas-based Nanoscope Therapeutics is accelerating the development of therapies that could restore sight in patients with the help of a publicly traded firm. The retinal degenerative diseases-focused biotech company announced a new gene therapy manufacturing partnership with contract research organization Charles River Laboratories International.
MORE
Meet the 43 Finalists for the 2022 Tech Titans Awards
Every year, Tech Titans highlights the top movers and shakers in the North Texas technology ecosystem. Here are the finalists in 11 categories. Winners will be announced at the group's signature gala in October.
MORE

DI People: City of Frisco, SMU, UNT, CBRE, Aero Design Labs, Invited, T.D. Jakes Foundation, and More Leadership Moves

by | Jun 3, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from The DEC, American Airlines, Perimeter Medical, BRIX, NEC Corp. of America, Valor, Vizient, Apty, DHA Housing Solutions for North Texas, Southwest Airlines, Nanoscope Therapeutics, TimelyMD, and Thryv Holdings.
MORE
Meet the Finalists: The Innovation Awards 2022, Presented by Dallas Innovates and D CEO
Now in its third year, the program from Dallas Innovates and D CEO honors 78 disruptors and trailblazers driving a new vision for innovation in North Texas.
MORE
EYE DNA DALLAS STARTUP GENE THERAPY
Bedford Biotech Restores “Meaningful Vision” in Blind Patients With Gene Therapy—and May Soon Go Public
by | Jun 22, 2021
Nanoscope Therapeutics successfully treated 11 patients blinded by advanced retinitis pigmentosa (RP). A single intravitreal injection produced positive results that persisted through one year. The startup plans a Phase 2b trial this summer and plans to develop gene therapies to treat more common retinal diseases—like dry age-related macular degeneration.
MORE
Nanoscope Therapeutics Closes Series A, Names Alvaro Guillem as Chairman
by | Jul 21, 2020
Nanoscope Therapeutics, a TechFW client, has closed an over-subscribed Series A funding round for its leading work on retinas, which could enable the blind to see.

In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
MORE